noscript

News and Announcements

OncoSil strengthens management team

  • Published October 08, 2015 11:14AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

8th October 2015, ASX Announcement

OncoSil Medical Limited (ASX:OSL) (OncoSil Medical, the Company) is pleased to announces details of two new key appointments to its senior management team in preparation for the commercialisation of the Company’s OncoSilTM localised radiation treatment for cancer.

Mr David James appointed Global Head of Manufacturing Operations 

Mr David James has been appointed the Company’s Global Head of Manufacturing Operations on a full-time basis effective from 5 October 2015, after initially working in the role in a part-time consultancy capacity since February.

Mr James is a highly experienced pharmaceutical manufacturing operations executive with more that 20 years’ experience in this field, including six years with leading cancer treatment company Sirtex Medical (ASX:SRX) as Global Operations Manager.

Dr Greg Rogers appointed Manufacturing Engineering Manager 

The Company is also pleased to advise the appointment of Dr Greg Rogers as Manufacturing Engineering Manager, effective from 2 Novemebr 2015.

To read the full announcement please click here

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now